Literature DB >> 19444071

Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications.

Michael J Lee1, Mark Dumonski, Patrick Cahill, Tom Stanley, Daniel Park, Kern Singh.   

Abstract

STUDY DESIGN AND
OBJECTIVE: This study performs a meta-analysis to compare complication rates from vertebroplasty (VP) and kyphoplasty (KP). SUMMARY OF BACKGROUND DATA: Recently, the development of VP and balloon KP has been shown to provide symptomatic relief and restoration of sagittal alignment of vertebral compression fractures refractory to medical therapy. Complications in treatment of vertebral compression fractures are rare, however can be potentially devastating. Fortunately, clinical sequelae are rare; however, severe clinical complications from cement extravasation have been reported.
METHODS: Using PubMed and Ovid, we performed a literature search for "kyphoplasty," "vertebroplasty," and "vertebral augmentation." This search was performed in December 2006. Case reports and reports not available in English were excluded. We categorized complications in 3 categories: (1) procedure-related complications, (2) medical complications, and (3) new vertebral fracture. Cement leakage, asymptomatic and symptomatic, and its locations were recorded. We performed a meta-analysis of complications of all studies. We then repeated the meta-analysis examining only prospective studies. We then used proportion analysis to determine statistical significance. We defined statistical significance as a P value less than 0.05.
RESULTS: We identified 121 reports of KP and/or VP that specifically addressed complications. Of these studies, 33 addressed KP and 82 addressed VP (6 reports addressed complications of both). There were 29 reports in which the data appeared to be collected prospectively. Of these, 9 addressed KP and 21 addressed VP.VP was found to have a significantly increased rate of procedure-related complications than KP in the analysis of all studies and only prospective studies. VP also appears to have a significantly higher rate of symptomatic and asymptomatic cement leakage than KP (P < 0.05). The incidence of medical complications was significantly higher in the KP procedure; however, this difference was not observed when analyzing only prospective studies. The incidence of new fracture was significantly higher in the VP procedure; however, this was not observed when analyzing only prospective studies.
CONCLUSION: VP and KP are 2 minimally invasive procedures that have been shown to be effective in the treatment of symptomatic vertebral compression fractures. Although the incidence of adverse events for both VP and KP are low, it appears that VP is associated with a statistically significant increased rate of procedure-related complications and cement extravasation (symptomatic and asymptomatic). Future prospective studies with large patient enrollment will be needed to further validate the finding of this meta-analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19444071     DOI: 10.1097/BRS.0b013e3181a3c742

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  74 in total

1.  Safety of balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures in Europe: a meta-analysis of randomized controlled trials.

Authors:  Carmen Bouza; Teresa López-Cuadrado; Nuria Almendro; José María Amate
Journal:  Eur Spine J       Date:  2014-11-16       Impact factor: 3.134

2.  Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta-analysis of randomised and non-randomised controlled trials.

Authors:  Shiliang Han; Shuanglin Wan; Lei Ning; Yongjun Tong; Jianfeng Zhang; Shunwu Fan
Journal:  Int Orthop       Date:  2011-06-03       Impact factor: 3.075

3.  CT fluoroscopy-guided percutaneous vertebroplasty in spinal malignancy: technical results, PMMA leakages, and complications in 202 patients.

Authors:  Christoph G Trumm; Anne Pahl; Thomas K Helmberger; Tobias F Jakobs; Christoph J Zech; Robert Stahl; Philipp M Paprottka; Torleif A Sandner; Maximilian F Reiser; Ralf-Thorsten Hoffmann
Journal:  Skeletal Radiol       Date:  2012-11       Impact factor: 2.199

4.  Lateral wedging of the cemented vertebra after balloon kyphoplasty: a case report.

Authors:  Heng Wang; Zhenzhong Sun; Joshi Nitesh; Huilin Yang; Weimin Jiang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 5.  Health economic aspects of vertebral augmentation procedures.

Authors:  F Borgström; D P Beall; S Berven; S Boonen; S Christie; D F Kallmes; J A Kanis; G Olafsson; A J Singer; K Åkesson
Journal:  Osteoporos Int       Date:  2014-11-08       Impact factor: 4.507

6.  Osteoporotic vertebral fractures without compression: key factors of diagnosis and initial outcome of treatment with cement augmentation.

Authors:  Haiqing Mao; Jun Zou; Dechun Geng; Xuesong Zhu; Mo Zhu; Weimin Jiang; Huilin Yang
Journal:  Neuroradiology       Date:  2012-02-25       Impact factor: 2.804

7.  Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading?

Authors:  K L Ong; E Lau; J E Kemner; S M Kurtz
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

8.  Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients.

Authors:  Si-Yuan Zhu; Zhao-Ming Zhong; Qian Wu; Jian-Ting Chen
Journal:  Int Orthop       Date:  2016-01-12       Impact factor: 3.075

9.  Vertebroplasty for osteoporotic fracture? Think twice.

Authors:  Scott Kinkade; James J Stevermer
Journal:  J Fam Pract       Date:  2009-12       Impact factor: 0.493

10.  Vertebroplasty for pain relief and spinal stabilization in multiple myeloma.

Authors:  Flavio Tancioni; Martin Lorenzetti; Pierina Navarria; Andrea Nozza; Luca Castagna; Paolo Gaetani; Enrico Aimar; Daniel Levi; Antonio Di Ieva; Patrizia Pisano; Armando Santoro; Marta Scorsetti; Riccardo Rodriguez y Baena
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.